ConductScience.org, home

Paper20439609

Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.

Lanier ER and 9 others. Antimicrob Agents Chemother, 2010. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV. Papers, record 20439609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20439609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2021-10-20
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lanier ERE Randall
2Ptak RGRoger G
3Lampert BMBernhard M
4Keilholz LLaurie
5Hartman TTracy
6Buckheit RW JrRobert W
7Mankowski MKMarie K
8Osterling MCMark C
9Almond MRMerrick R
10Painter GRGeorge R

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenineMajor topic
Anti-HIV AgentsMajor topic
HIV InfectionsMajor topic
NucleosidesMajor topic
NucleotidesMajor topic
OrganophosphonatesMajor topic
Cell Survival
Cells, Cultured
Drug Resistance, Viral
HIV-1
Humans
Macrophages
Tenofovir

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117646420Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17646420PubMed
218398970Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.J Acquir Immune Defic Syndr2008https://conductscience.org/library/papers/18398970PubMed
310479128Viral and immunologic examination of human immunodeficiency virus type 1-infected, persistently seronegative persons.J Infect Dis1999https://conductscience.org/library/papers/10479128PubMed
417106280Predictors of antiretroviral treatment failure in an urban HIV clinic.J Acquir Immune Defic Syndr2007https://conductscience.org/library/papers/17106280PubMed
59620997Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.J Virol1998https://conductscience.org/library/papers/9620997PubMed
610207549
Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results. Seronegative AIDS Clinical Study Group.
AIDS1999https://conductscience.org/library/papers/10207549PubMed
79094670Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection.J Virol1997https://conductscience.org/library/papers/9094670PubMed
814976601Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients.J Infect Dis2004https://conductscience.org/library/papers/14976601PubMed
915633092Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.J Infect Dis2005https://conductscience.org/library/papers/15633092PubMed
103258626Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.J Exp Med1988https://conductscience.org/library/papers/3258626PubMed
116200935Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.Science1984https://conductscience.org/library/papers/6200935PubMed
123481271Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/3481271PubMed
1320068260Update of the drug resistance mutations in HIV-1: December 2009.Top HIV Med2009https://conductscience.org/library/papers/20068260PubMed
149243042Absence of detectable antibody in a patient infected with human immunodeficiency virus.Clin Infect Dis1997https://conductscience.org/library/papers/9243042PubMed
1519289522Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19289522PubMed
1617005808Mechanism of active renal tubular efflux of tenofovir.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/17005808PubMed
1714742192Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14742192PubMed
1815283988Design and development of oral drugs for the prophylaxis and treatment of smallpox infection.Trends Biotechnol2004https://conductscience.org/library/papers/15283988PubMed
191729362Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN.J Immunol1992https://conductscience.org/library/papers/1729362PubMed
209256156Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.Biochem Pharmacol1997https://conductscience.org/library/papers/9256156PubMed

See all 45 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
40969871Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron Incorporation.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40969871PubMed
38005911The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors.Viruses2023https://conductscience.org/library/papers/38005911PubMed
36477356Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques.JCI Insight2022https://conductscience.org/library/papers/36477356PubMed
35891417HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant Gnidia sericocephala (Thymelaeaceae).Viruses2022https://conductscience.org/library/papers/35891417PubMed
34985256Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation.ACS Infect Dis2022https://conductscience.org/library/papers/34985256PubMed
33490040Overview of Biologically Active Nucleoside Phosphonates.Front Chem2020https://conductscience.org/library/papers/33490040PubMed
33262821Investigational drugs with dual activity against HBV and HIV (Review).Exp Ther Med2021https://conductscience.org/library/papers/33262821PubMed
32389360Hepatitis B: Current Status of Therapy and Future Therapies.Gastroenterol Clin North Am2020https://conductscience.org/library/papers/32389360PubMed
31469328Phosphonate prodrugs: an overview and recent advances.Future Med Chem2019https://conductscience.org/library/papers/31469328PubMed
29802984Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema.Eur J Pharm Biopharm2019https://conductscience.org/library/papers/29802984PubMed
29433097Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.J Pharm Biomed Anal2018https://conductscience.org/library/papers/29433097PubMed
26088266Investigational reverse transcriptase inhibitors for the treatment of HIV.Expert Opin Investig Drugs2015https://conductscience.org/library/papers/26088266PubMed
25849312
β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms.
J Med Chem2015https://conductscience.org/library/papers/25849312PubMed
25302989Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication.J Chem Inf Model2014https://conductscience.org/library/papers/25302989PubMed
24278679The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance.Scientifica (Cairo)2012https://conductscience.org/library/papers/24278679PubMed
24217696Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24217696PubMed
23722347Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23722347PubMed
23554824Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.Drug Discov Today Technol2012https://conductscience.org/library/papers/23554824PubMed
22912836Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.PLoS One2012https://conductscience.org/library/papers/22912836PubMed
22878694Update on tenofovir toxicity in the kidney.Pediatr Nephrol2013https://conductscience.org/library/papers/22878694PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20439609

GET https://conductscience.org/api/papers/v1/20439609/references?page=2